Protective effect of curcumin against lead neurotoxicity in rat

Human and Experimental Toxicology

Volumn 22, Issue 12, 2003, Pages 653-658

  Shukla, Pradeep K ^a   Khanna, Vinay K ^a   Khan, Mohd Y ^b   Srimal, Rikhab C ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

Author keywords

Brain; Curcumin; Lead; Neuroprotection; Oxidative stress

Indexed keywords

CATALASE; CURCUMIN; GLUTATHIONE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN REGION; CEREBELLUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; FRONTAL CORTEX; HIPPOCAMPUS; LEAD POISONING; LIPID PEROXIDATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, ORAL; ANIMALS; CATALASE; CEREBELLUM; CORPUS STRIATUM; CURCUMIN; DRUG ADMINISTRATION SCHEDULE; GLUTATHIONE; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MOTOR CORTEX; NEUROTOXICITY SYNDROMES; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TISSUE DISTRIBUTION;

CURCUMA LONGA; FELIS CATUS;

EID: 1242307990     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327103ht411oa     Document Type: Article

References (29)

1. Villeda-Hernandez J, Barroso-Moguel R, Mendez-Armenta M, Nava-Ruiz C, Huerta-Romero R, Rios C. Enhanced brain regional lipid peroxidation in developing rats exposed to low level lead acetate. Brain Res Bull 2001; 55: 247-51.
2. Widzowski DV, Cory-Slechta DA. Homogeneity of regional brain lead concentrations. Neurotoxicology 1994; 15: 295-308.
3. Klaassan CD. Heavy metals and heavy metal antagonist. In Gilman AG, Rall TW, Nilb AS, Taylor P eds. Parmacological basis of therapeutics. New York: Pergamon, 1991: 1592-614.
4. Lucchini R, Albini E, Cortesi I, Placidi D, Bergamaschi E, Traversa F, Alessio L. Assesment of neurobehavioural performance as a function of current and cumulative occupational lead exposure. Neurotoxicology 2000; 21: 805-12.
5. Rothenberg SJ, Selvaas L, Perroni E, Hernadez RN, Martinez S, Hernandez C. Pre- and postnatal lead effect on head circumference: a case for critical periods. Neurotoxicol Teratol 1999; 21: 1-11.
6. Prpic-Majic D, Bobic J, Simic D, House DE, Otto DA, Jurasovic J, Piznet A. Lead absorption and psychological function in Zagreb (Croatia) school children. Neurotoxicol Teratol 2000; 22: 347-56.
7. Ribarov SR, Bochev PG. Lead haemoglobin interaction as possible source of reactive species - a chemiluminescent study. Arch Biochem Biophys 1982; 213: 288-92.
8. Monteiro HP, Bdalla DSP, Arcuri AS, Bechara EJH. Oxygen toxicity related to treatment of lead. Clin Chem 1985; 31: 1673-76.
9. Adonaylo VN, Oteiza PI. Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology 1999; 135: 77-85.
10. Senapati SK, Dey S, Dwivedi SK, Swarup D. Effect of garlic (Allium sativum L.) extract on tissue lead level in rats. J Ethnopharmacol 2001; 76: 229-332.
11. Gurer H, Ozgunes H, Oztezcan S, Ercal N. Antioxidant role of α-lipoic acid in lead toxicity. Free Radic Biol Med 1999; 27: 75-81.
12. Srimal RC. Turmeric: a brief review of medicinal properties. Fitoterapia 1997; LXVIII: 483-93.
13. Sharma SC, Mukhtar H, Sharma SK, Krishnamurti CR. Lipid peroxide formation in experimental inflammation. Biochem Pharmacol 1972; 21: 1210-14.
14. Limtrakul P, Lipigorngoson S, Namwong O, Apisariyakul A, Dunn FW. Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Letts 1997; 116: 197-203.
15. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin. A naturally occuring plant phenolic compound. Cancer Res 1995; 55: 259-66.
16. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL. Curcumin containing diet inhibits diethylnitrosamine induced murine hepatocarcinogenesis. Carcinogenesis 2000; 21: 331-35.
17. Thapliyal R, Naresh KN, Rao KVK, Maru GB. inhibition of nitrosodiethylamine-induced hepatocarcinogenesis by dietary turmeric in rats. Toxicol Letts 2003; 139: 45-54.
18. Das KC, Das CK. Cucumin (difruloylmethane), a singlet oxygen (O-1(2))quencher. Biochem Biophys Res Commun 2002; 295: 62-66.
19. Miquel J, Bernd A, Sempere JM, Diaz-Alperi J, Ramirez A. The curcuma antioxidants: pharmacological effects and prospects for future clinical use. Arch Gerentol Geriatr 2002; 34: 37-46.
20. Soudamini KK, Unnikrishnan MC, Soni KB, Kuttan R. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physol Pharmacol 1992; 36: 239-43.
21. 3H-dopa in various regions of the brain. J Neurochem 1966; 13: 655-59.
22. Bohme DH, Kosechzi R, Carsen S, Stern F, Marks N. Lipid peroxidation in human and rat brain tissue: developmental and regional studies. Brain Res 1977; 136: 11-21.
23. Hasan M, Haider SS. Acetyl-homseocystein thiolactone protect against same neurotoxic effects of thallium. Neurotoxicology 1989; 10: 257-62.
24. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophy 1984; 21: 130-32.
25. Sinha AK. Colometric assay of catalase. Anal Biochem 1972; 47: 389-94.
26. Lowry OH, Rosebrough NJ, Forr AL, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
27. Sandhir R, Julka D, Gill KD. Lipoperoxidative damage on lead treatment in rat brain and its implication on membrane bounds enzymes. Pharmacol Toxicol 1994; 74: 66-71.
28. Park Eun-Jeon, Jeon Chul Hyun, Ko Geonil, Kim Jaebaek, Sohn Dong Hwan. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J Pharm Pharmacol 2000; 52: 437-40.
29. Mitchell T. A report on curcumin's anti-cancer effects. LE Magazine July 2000: 1-8.